Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih‐Lin Lin, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 605-622
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 777-777
Open Access | Times Cited: 8
Perceived HBV‐Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B
Hee‐Soon Juon, Daniel Yang, Chunxiao Fang, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 3
Open Access | Times Cited: 1
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues
Jun Inoue, Shinichiro Minami, Kazumichi Abe, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 4
Open Access | Times Cited: 1
Editorial: How to Interpret Clinical Impact of Viral Replication Activity for Postoperative Recurrence of HBV‐Related HCC
Beom Kyung Kim
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do
Walaa Abdelhamed, Mohamed El‐Kassas
Liver Research (2024) Vol. 8, Iss. 2, pp. 83-90
Open Access | Times Cited: 7
Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients
Chinmay Bera, Nashla Hamdan‐Pérez, Keyur Patel
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1046-1046
Open Access | Times Cited: 6
Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
Mi Na Kim, Kyungdo Han, Juhwan Yoo, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 8, pp. 1448-1458
Closed Access | Times Cited: 16
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 5
Hepatitis B virus infection and its treatment in Eastern Ethiopia
Tatsuo Kanda, Reina Sasaki, Atsunori Tsuchiya, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 1
Closed Access
Liver histological study of patients with chronic hepatitis B virus infection in the grey zone
Weijia Lin, Rongrong Ding, Shuangshuang Sun, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model
Yifan Li, Lan‐Qing Yao, Chao Li, et al.
Annals of Surgical Oncology (2025)
Closed Access
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)
Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, et al.
Infectious Diseases and Therapy (2025)
Open Access
Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP‐1RA in CHB and T2DM Patients
Byungyoon Yun, Juyeon Oh, Heejoo Park, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis
Nobuharu Tamaki, Daniel Q. Huang, Hyung Woong Lee, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort
Jeong‐Ju Yoo, Young‐Gi Song, Ji Eun Moon, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1953-1955.e1
Closed Access | Times Cited: 3
Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score
Qi Wang, Shugui Sheng, Yiqi Xiong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B
Ploutarchos Pastras, Evaggelos Zazas, Maria Kalafateli, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2521-2521
Open Access | Times Cited: 3
Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 887-887
Open Access | Times Cited: 2
Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB
Shaowen Jiang, Simin Guo, Yan Huang, et al.
Antiviral Research (2024) Vol. 226, pp. 105892-105892
Open Access | Times Cited: 2
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
Moon Haeng Hur, Dong Hyeon Lee, Jeong‐Hoon Lee, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 500-514
Open Access | Times Cited: 2
Beta‐caryophyllene attenuates experimental hepatocellular carcinoma through downregulation of oxidative stress and inflammation
Zaved Ahmad, S. K. Jain, Siddhartha Kumar Mishra
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 10
Closed Access | Times Cited: 2
Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis
Qi‐Hang Cao, Hui Liu, Lun‐Jie Yan, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 8, pp. 1464-1475
Open Access | Times Cited: 1
Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis
Mi Na Kim, Jihyun An, Eun Hwa Kim, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. Suppl, pp. S106-S116
Open Access | Times Cited: 1
The unfolded features on the synchronized fashion of gut microbiota and Drynaria rhizome against obesity via integrated pharmacology
Ki‐Kwang Oh, Sang Jun Yoon, Seol Hee Song, et al.
Food Chemistry (2024) Vol. 460, pp. 140616-140616
Open Access | Times Cited: 1
Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return
Sudheer Marrapu, Ramesh Kumar
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1151-1157
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top